Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
02 2022
Historique:
received: 15 11 2020
revised: 28 03 2021
accepted: 01 04 2021
pubmed: 29 5 2021
medline: 1 2 2022
entrez: 28 5 2021
Statut: ppublish

Résumé

Tricuspid atresia with normally related great vessels (TA) is considered the optimal substrate for the Fontan pathway. The factors associated with death or transplantation after cavopulmonary shunt (CPS) are underappreciated. We aimed to determine factors associated with CPS-Fontan interstage death/transplantation versus transition to Fontan in TA. A total of 417 infants younger than 3 months of age with TA were enrolled (January 1999 to February 2020) from 40 institutions into the Congenital Heart Surgeons' Society TA cohort. Parametric competing risk methodology was used to determine factors associated with the competing end points of death/transplantation without Fontan completion, and transition to Fontan. CPS was performed in 382 patients with TA; of those, 5% died or underwent transplantation without transition to Fontan and 91% transitioned to Fontan by 5 years after CPS. Prenatal diagnosis (hazard ratio [HR], 0.74; P < .001) and pulmonary artery band (PAB) at CPS (HR, 0.50; P < .001) were negatively associated with Fontan completion. Preoperative moderate or greater mitral valve regurgitation (HR, 3.0; P < .001), concomitant mitral valve repair (HR, 11.0; P < .001), PAB at CPS (HR, 3.0; P < .001), postoperative superior vena cava interventions (HR, 9.0; P < .001), and CPS takedown (HR, 40.0; P < .001) were associated with death/transplantation. The mortality rate after CPS in patients with TA is notable. Those with preoperative mitral valve regurgitation remain a high-risk group. PAB at the time of CPS being associated with both increased risk of death and decreased Fontan completion may represent a deleterious effect of antegrade pulmonary blood flow in the CPS circulation.

Identifiants

pubmed: 34045062
pii: S0022-5223(21)00745-5
doi: 10.1016/j.jtcvs.2021.04.061
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-409.e6

Investigateurs

Aaron M Abarbanell (AM)
David J Barron (DJ)
Christopher A Caldarone (CA)
William M DeCampli (WM)
Pirooz Eghtesady (P)
Peter J Gruber (PJ)
S Adil Husain (SA)
Marshall L Jacobs (ML)
Anusha Jegatheeswaran (A)
Tara Karamlou (T)
Linda Lambert (L)
Brian W McCrindle (BW)
David B Meyer (DB)
David M Overman (DM)
Christian Pizarro (C)
Karthik Ramakrishnan (K)
James D St Louis (JD)
Karl F Welke (KF)
Varsha Zadokar (V)

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Connor P Callahan (CP)

Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario Canada.

Anusha Jegatheeswaran (A)

Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario Canada.

David J Barron (DJ)

Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario Canada.

S Adil Husain (SA)

Division of Pediatric Cardiothoracic Surgery, Primary Children's Hospital, Salt Lake City, Utah.

Pirooz Eghtesady (P)

Department of Pediatric Cardiothoracic Surgery, St. Louis Children's Hospital, St Louis, Mo.

Karl F Welke (KF)

Division of Pediatric Cardiac Surgery, Levine Children's Hospital, Charlotte, NC.

Christopher A Caldarone (CA)

Division of Congenital Heart Surgery, Texas Children's Hospital, Houston, Tex.

David M Overman (DM)

Division of Cardiovascular Surgery, Children&apos;s Minnesota, Minneapolis, and Mayo Clinic-Children&apos;s Minnesota Cardiovascular Collaborative, Rochester, Minn.

James K Kirklin (JK)

Division of Cardiothoracic Surgery, Department of Surgery, The University of Alabama at Birmingham, Birmingham, Ala.

Marshall L Jacobs (ML)

Division of Cardiac Surgery, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Md.

Linda M Lambert (LM)

Division of Pediatric Cardiothoracic Surgery, Primary Children's Hospital, Salt Lake City, Utah.

William M DeCampli (WM)

Division of Pediatric Cardiac Surgery, Arnold Palmer Hospital for Children, Orlando, Fla.

Brian W McCrindle (BW)

Division of Pediatric Cardiology, The Hospital for Sick Children, Toronto, Ontario Canada. Electronic address: Brian.mccrindle@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH